NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pharmacology/Insulin and Oral Hypoglycemics
    Insulin and Oral Hypoglycemics
    medium
    pill Pharmacology

    A 52-year-old man with type 2 diabetes mellitus on metformin monotherapy presents with progressive fatigue, paresthesias, and macrocytic anemia (Hb 9.2 g/dL, MCV 108 fL). Serum creatinine is 1.8 mg/dL. Which investigation is most appropriate to confirm the suspected adverse effect of his current medication?

    A. Peripheral blood smear and reticulocyte count
    B. Tissue transglutaminase (tTG) IgA antibodies
    C. Intrinsic factor antibodies and parietal cell antibodies
    D. Serum vitamin B12 and methylmalonic acid levels

    Explanation

    ## Clinical Context This patient presents with the classic triad of **metformin-associated vitamin B12 deficiency**: macrocytic anemia, neurological symptoms (paresthesias), and fatigue. Metformin impairs B12 absorption in the terminal ileum by reducing intrinsic factor-mediated uptake and altering calcium-dependent B12 transport, particularly in patients with renal impairment (eGFR <30 mL/min/1.73m²). ## Investigation of Choice **Key Point:** Serum vitamin B12 and methylmalonic acid (MMA) levels are the gold-standard confirmatory tests for B12 deficiency. - **Serum B12**: Directly measures circulating cobalamin; low levels (<200 pg/mL) confirm deficiency - **Methylmalonic acid**: Elevated in true B12 deficiency (>0.4 μmol/L) because B12 is a cofactor for methylmalonyl-CoA mutase; this test distinguishes true deficiency from folate deficiency or other causes of macrocytosis - **Homocysteine**: Also elevated in B12 deficiency; can be measured simultaneously **High-Yield:** The combination of low B12 + elevated MMA is pathognomonic for B12 deficiency and is more specific than B12 level alone, which can be low-normal in early deficiency. ## Why This Matters in Metformin Use | Feature | Metformin-Induced B12 Deficiency | | --- | --- | | Mechanism | Reduced intrinsic factor-mediated absorption in terminal ileum | | Risk factors | Renal impairment (Cr >1.5), prolonged use (>5 years), age >50 | | Incidence | 10–30% of long-term users | | Management | B12 supplementation (oral or IM); continue metformin if renal function permits | **Clinical Pearl:** Metformin-induced B12 deficiency is NOT due to autoimmune gastritis (unlike pernicious anemia), so intrinsic factor antibodies will be negative. This distinguishes it from autoimmune causes. ## Diagnostic Algorithm ```mermaid flowchart TD A[Macrocytic anemia + neurological symptoms on metformin]:::outcome --> B[Measure serum B12]:::action B --> C{B12 low?}:::decision C -->|Yes| D[Measure methylmalonic acid & homocysteine]:::action D --> E{Both elevated?}:::decision E -->|Yes| F[Confirm B12 deficiency]:::outcome E -->|No| G[Consider folate deficiency or other cause]:::outcome C -->|Normal| H[Check folate, TSH, reticulocyte count]:::action ```

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pharmacology Questions